SeaCrest Wealth Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Buy |
19,700
+2,100
| +12% | +$19.4K | 0.02% | 588 |
|
|
2025
Q1 | $151K | Buy |
17,600
+2,300
| +15% | +$19.7K | 0.02% | 635 |
|
|
2024
Q4 | $164K | Buy |
+15,300
| New | +$164K | 0.02% | 628 |
|
|
2022
Q3 | – | Sell |
-4,375
| Closed | -$44K | – | 691 |
|
|
2022
Q2 | $44K | Buy |
+4,375
| New | +$44K | 0.01% | 1171 |
|
|
2022
Q1 | – | Sell |
-13,075
| Closed | -$227K | – | 717 |
|
|
2021
Q4 | $227K | Sell |
13,075
-1,400
| -10% | -$24.3K | 0.02% | 604 |
|
|
2021
Q3 | $260K | Buy |
14,475
+650
| +5% | +$11.7K | 0.03% | 533 |
|
|
2021
Q2 | $316K | Buy |
+13,825
| New | +$316K | 0.04% | 484 |
|